Regular use of low-dose aspirin may increase an older person’s risk of being diagnosed with advanced cancer and of dying from cancer, results from the ASPREE clinical trial suggest. Learn more about what this 19,000-participant study found.
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2Fv6qpb
from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/2Fv6qpb